Anti-C1q antibodies in lupus nephritis: Detection and relationship with disease activity

Bibliographic Information
Authors: Raafat M.; Nabil M.; AbouZeid S.; Hassanein A.S.
Journal: Life Science Journal
Publisher: Zhengzhou University
Publication Date: 2014
Volume / Issue: Volume 11 / Issue 12
Pages: 940–946
ISSN: 10978135
DOI: 10.7537/marslsj111214.163
Scopus: View on Scopus
Document Type: Article
Authors and Affiliations
Raafat M., Nephrology Departments, Theodor Bilharz Research Institute, Cairo, Egypt; Nabil M., Nephrology Departments, Theodor Bilharz Research Institute, Cairo, Egypt; AbouZeid S., Nephrology Departments, Theodor Bilharz Research Institute, Cairo, Egypt; Hassanein A.S., Hematology Departments, Theodor Bilharz Research Institute, Cairo, Egypt, AL-Ghad International College for Applied Medical Sciences for Girls, Jeddah, Saudi Arabia
Abstract
Background: Systemic Lupus Erythromatosis (SLE) is a multisystem autoimmune disorder with a broad spectrum of clinical presentations. Glomerulonephritis is one of the commonest and most serious manifestations of SLE. Several autoantibodies, especially those against double stranded DNA (anti-dsDNA), are believed to play a major role in the induction of glomerular inflammation. C1q is a multifunctional protein that binds to immune complexes deposited on tissues, including the kidney and aids in their solubilization and removal. C1q also plays a role in apoptotic cell debris removal. The binding of anti-C1q antibodies and other proteins to C1q is potentially of concern as it may impede the ability of C1q to carry out its normal anti-inflammatory functions such as immune complex clearance and removal of apoptotic debris. The aim of the present study: to evaluate the presence of anti- C1q antibodies in patients with SLE, with and without renal involvement, and to correlate their presence and levels with disease activity and occurrence of nephropathy. Method: Forty SLE patients were recruited in the study, they were divided in two groups according to their clinical status and laboratory investigations, group 1 was comprised 15 SLE patients without evidence of nephritis while Group 2 comprised 25 SLE patients who were diagnosed to have lupus nephritis. Sera were tested for anti C1q by ELISA technique. Result: A statistical significant difference between group 1 and 2 as regard anti- C1q (p = 0.002) was noticed. In those with lupus nephritis, anti-C1q was found to correlate significantly with other parameters assessing lupus activity such as ESR (p =0.017), creatinine clearance, (p =0.029), proteinuria (p =0.003), and Anti-dsDNA (p =0.014). Conclusion: Anti-Clq autoantibodies correlate with renal disease activity and with renal flare-ups like other standard parameters, such as proteinuria, complement levels anti-dsDNA. Anti-C1q antibodies can be considered as a reliable sensitive and specific biomarker to diagnose nephritis flare in patients with SLE. © 2014, Zhengzhou University. All rights reserved.
Keywords
Anti-dsDNA; C1q; SLE
Citation Information
Scopus Citations: 0
For comprehensive information about the Theodor Bilharz Research Institute (TBRI), its institutional activities, scientific and research achievements, clinical and hospital services, and the diverse expertise offered through its 22 specialized research and clinical departments, as well as opportunities for professional training, specialized workshops, and scientific conferences, readers are invited to visit the Institute’s official website.
The website provides regularly updated information on the Institute’s latest news, research activities, scientific initiatives, clinical services, institutional programs, and academic and professional opportunities.
English Website: https://www.tbri.sci.eg/en/
Arabic Website: https://www.tbri.sci.eg/ar/
Prepared and Uploaded by:
Abdalla F. Abdalla
Electronic Portal Unit
